Catalent

Catalent signs on to produce Aurinia's newly approved lupus nephritis drug
Catalent signs on to produce Aurinia's newly approved lupus nephritis drug
Fierce Pharma
Catalent
Aurinia Pharmaceuticals
lupus nephritis
Lupkynis
CDMOs
Flag link:
Catalent continues big push into cell and gene therapies with Belgian facility buyout
Catalent continues big push into cell and gene therapies with Belgian facility buyout
Fierce Pharma
CDMO
Catalent
Belgium
cell therapy
gene therapy
Flag link:
AstraZeneca ropes in Catalent gene therapy site to produce viral vectors for COVID-19 vaccine
AstraZeneca ropes in Catalent gene therapy site to produce viral vectors for COVID-19 vaccine
Fierce Pharma
AstraZeneca
Catalent
CDMO
vaccines
COVID-19
Flag link:
Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s Covid-19 vaccine candidate
Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s Covid-19 vaccine candidate
Pharmaceutical Business Review
Moderna Therapeutics
Catalent
drug manufacturing
vaccines
COVID-19
pandemic
mRNA-1273
Flag link:
Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal
Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal
Fierce Pharma
Moderna Therapeutics
vaccines
pandemic
COVID-19
Catalent
CDMO
Flag link:
Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine
Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine
Reuters
Arcturus Therapeutics
Catalent
vaccines
COVID-19
Flag link:
Catalent and Johnson & Johnson Sign Coronavirus Vaccine Manufacturing Deal
Catalent and Johnson & Johnson Sign Coronavirus Vaccine Manufacturing Deal
Motley Fool
JNJ
Catalent
COVID-19
vaccines
drug manufacturing
Flag link:
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Fierce Pharma
Perrigo
Catalent
Teva Pharmaceutical
ProAir HFA
asthma
COPD
generics
Flag link:
Catalent laying out $315M to snatch another gene therapy CDMO
Catalent laying out $315M to snatch another gene therapy CDMO
Fierce Pharma
Catalent
gene therapy
Paragon Services
CDMOs
Flag link:
Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win
Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win
Motley Fool
insurers
generics
Catalent
Flag link:
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Yahoo/Zacks.com
Allergan
Regeneron
Mylan
Catalent
Jazz Pharmaceuticals
Flag link:
This Company Is Looking to Win Big in Gene Therapy
This Company Is Looking to Win Big in Gene Therapy
Motley Fool
Catalent
gene therapy
drug manufacturing
Flag link:
Catalent picks up Novavax facilities, 100 employees
Catalent picks up Novavax facilities, 100 employees
Biopharma Dive
Paragon Gene Therapy
Catalent
CMO
Novavax
Flag link:
'It's a growth play': Catalent acquires Bristol-Myers' European launch pad, expanding global CDMO ops
'It's a growth play': Catalent acquires Bristol-Myers' European launch pad, expanding global CDMO ops
Endpoints
Catalent
Europe
Bristol-Myers Squibb
Italy
gene therapy
CDMOs
Flag link:
Scratch that: Biogen's board expansion hits snag as Catalent CEO John Chiminski drops out
Scratch that: Biogen's board expansion hits snag as Catalent CEO John Chiminski drops out
Fierce Pharma
Biogen
John Chiminski
Catalent
Flag link:
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon
Xconomy
gene therapy
M&A
Catalent
Paragon Bioservices
Flag link:
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
Endpoints
Catalent
Juniper Pharmaceuticals
UK
M&A
drug development
Flag link:
With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica
With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica
Endpoints
CROs
Catalent
M&A
Cook Pharmica
R&D
Flag link:
Catalent Rises on Report Lonza Group Offered to Buy It
Catalent Rises on Report Lonza Group Offered to Buy It
Bloomberg
Catalent
Lonza
drug delivery
M&A
Flag link:
China Biotech In Review: Simcere Receives $503 Million Privatization Offer
China Biotech In Review: Simcere Receives $503 Million Privatization Offer
Seeking Alpha
Simcere
Shanghai Pharmaceutical
Catalent
ShangPharma
Pathwork Diagnostics
Sinovac Biotech
BravoBio
Flag link:

Pages